Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by Joemare


T.TH

RE:Validation for PDCs

As days go by in March, not sure where we stand with the peptide. But one...

March 29, 2023

T.TH

Are the executives and the board that dumb and unware?

Biggest flop is lack of NASH roadmap and partnership.  Wasted three...

March 28, 2023

T.TH

Fire the coach, fire the GM, fire the president, fire scouts

That's how it's done in professional sports. No reason not to apply...

March 13, 2023

T.TH

RE:Deal or No deal

Excellent post. Can no longer be on the fence. IN or OUT. OUT = slash costs...

March 13, 2023

T.TH

RE:RE:RE:RE:RE:RE:Cantor sticking with their Buy and $9 price target

They have a hard time executing.  Not funny now. This is another proof.&...

February 28, 2023

T.TH

RE:Is this a game changer

Well, two PR before the CC is a good sign. However, if they can't ink a...

February 23, 2023

T.TH

RE:From Linkedin

Embargo : https://www.croiconference.org/embargo-and-press-release-policies/ ...

February 20, 2023

T.TH

The path forward announced today

I'm not sure if I should pull the hair off my head or jump with joy. ...

February 16, 2023

T.TH

RE:Posted on LinkedIn

If prensentation will have anything of significance - i.e. trial is back on...

February 15, 2023

T.TH

More bad news to come on Feb 28. Unfortunately.

'Business update' plugged in a quater/annual review is never a good...

February 15, 2023

T.TH

RE:RE:RE:RE:RE:Earnings

I believe the are legally obligated to provide final financials three-months...

February 10, 2023

T.TH

RE:RE:RE:RE:Alogos news

They need to report those changes now and build on the year-end call...

February 9, 2023

T.TH

Right now, the best thing that can happen

Is they issue a PR prior to their annual conference call stating some good...

February 8, 2023

T.TH

RE:RE:Paying a 2M$ salary to an executive that has not delivered

Reducing his salary and still gets a pass for failure to bring shareholder...

February 3, 2023

T.TH

Paying a 2M$ salary to an executive that has not delivered

He needs to go. He won't get my votes.  He faile.  The VP...

February 3, 2023

T.TH

Sortilin and hypertension -the protein that keeps on giving!

  December 2022   Purpose of review: The current review aims...

January 31, 2023

T.TH

RE:RE:RE:RE:RE:RE:RE:TH1902 ClinicalTrials.gov Update

Thera fatigue. Well said. Have the current executives and board reached...

January 30, 2023

T.TH

RE:New asset opportunities

Unfortunately, not a trust-worthy statement to put on a corporate slide. ...

January 27, 2023

T.TH

RE:RE:They act like big pharma. That's a problem

Well said. We don't even work for the company and we can clearly paint a...

January 20, 2023

T.TH

They act like big pharma. That's a problem

This tiny biotech, few employees in the US and Canada, mostly head-office or...

January 19, 2023

Prev 1 2 3 4 5 6 7 8 Next

Featured Company